Ogata et al. [36] used ultra-sensitive serial profiling Single-Molecule Array (Simoa) assays to quantitatively detect SARS-CoV-2 spike, the S1 subunit, and nucleocapsid antigens in the plasma of COVID-19 patients. The gene discussed is PSMD1; the disease is COVID-19.